Cargando…

Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

The chemical structure of a drug determines its physicochemical properties, further determines its ADME/Tox properties, and ultimately affects its pharmacological activity. Medicinal chemists can regulate the pharmacological activity of drug molecules by modifying their structure. Ring systems and f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Fei, Ni, Wei, Xu, Xiang, Wang, Hui, Wang, Jing, Ji, Min, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273477/ https://www.ncbi.nlm.nih.gov/pubmed/26771590 http://dx.doi.org/10.3390/molecules21010075

Ejemplares similares

Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery
por: Mao, Fei, et al.
Publicado: (2016)

Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
por: King, Emily A., et al.
Publicado: (2019)

Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers
por: Zou, Limin, et al.
Publicado: (2023)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022)

Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
por: Asano, Kunihito, et al.
Publicado: (2017)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery
por: Novick, Paul A., et al.
Publicado: (2013)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
por: O′Hagan, Steve, et al.
Publicado: (2014)

Predictors of orphan drug approval
por: Heemstra, Harald
Publicado: (2010)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020)

Drug repurposing strategy II: from approved drugs to agri-fungicide leads
por: An, Jun-Xia, et al.
Publicado: (2023)

DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development
por: Li, Qiang, et al.
Publicado: (2022)

Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent Escherichia coli ClpP Inhibitors
por: Sassetti, Elisa, et al.
Publicado: (2019)

Synthesis and clinical application of new drugs approved by FDA in 2022
por: Zhang, Jing-Yi, et al.
Publicado: (2023)

Towards Decoding Hepatotoxicity of Approved Drugs through Navigation of Multiverse and Consensus Chemical Spaces
por: López-López, Edgar, et al.
Publicado: (2023)

Correction to: DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development
por: Li, Qiang, et al.
Publicado: (2022)

Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017)

The use of mechanistic evidence in drug approval
por: Aronson, Jeffrey K., et al.
Publicado: (2018)

Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads
por: Ma, Yue, et al.
Publicado: (2022)

The US Food and Drug Administration's tentative approval process and the global fight against HIV
por: Chahal, Harinder Singh, et al.
Publicado: (2017)

Discrimination of approved drugs from experimental drugs by learning methods
por: Tang, Kailin, et al.
Publicado: (2011)

Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
por: Marschallinger, Julia, et al.
Publicado: (2015)

Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020)

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
por: Liang, Fei, et al.
Publicado: (2020)

The global landscape of approved antibody therapies
por: Lyu, Xiaochen, et al.
Publicado: (2022)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States
por: Hoshino, Yuko, et al.
Publicado: (2022)

Inferring Novel Indications of Approved Drugs via a Learning Method with Local and Global Consistency
por: Yan, Yan, et al.
Publicado: (2014)

Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs
por: Van Norman, Gail A.
Publicado: (2016)

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
por: Jiao, Kuo, et al.
Publicado: (2019)

An open science pathway for drug marketing authorization—Registered drug approval
por: Naudet, Florian, et al.
Publicado: (2021)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Characterizing RNA-binding ligands on structures, chemical information, binding affinity and drug-likeness
por: Fan, Cong, et al.
Publicado: (2023)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kpatg93p7qg0aeaid9vpa5qehg